How AI and Entrepreneurship Can Transform Brain Research and Neurological Care

AI and entrepreneurship can transform brain research by creating new forms of knowledge, accelerating clinical insight, improving understanding of neurological diseases, and enabling more effective, data-driven care at scale.

Building New Knowledge About the Brain

“We want to build a new kind of knowledge about the brain, capable of informing clinical research and helping to provide better care.”

This ambition sits at the heart of Karavela, founded by Alexis Thual alongside Charles and Bertrand. Their work focuses on tackling the brain—the most complex organ in the human body and the conductor of all others.

From Advanced Tech to Neuroscience Innovation

Alexis brings experience from leading technology and health data organizations, including Meta and Arkhn. His co-founders contribute deep expertise in AI and academic research, with backgrounds spanning Owkin and Inria Université Paris-Saclay.

Together, they combine:

• Artificial intelligence
• Clinical research expertise
• Entrepreneurial execution

This interdisciplinary approach is essential for advancing brain science.

AI as a Catalyst for Brain Research

Understanding the brain requires processing massive, complex datasets that exceed human analytical capacity.

AI enables researchers to:

• Identify hidden patterns in brain data
• Generate insights that inform clinical hypotheses
• Accelerate the translation of research into care

By structuring and analyzing brain-related data, AI helps transform raw information into actionable medical knowledge.

From Research to Neurological Care

Karavela’s mission extends beyond discovery to real-world impact.

By improving understanding of how the brain functions and malfunctions, their work aims to:

• Support earlier and more accurate diagnosis
• Inform treatment strategies
• Improve outcomes for patients with neurological diseases

This is particularly critical for conditions such as Alzheimer’s disease, which affects millions of people worldwide.

Tackling Neurological Diseases at Scale

With approximately 10 million new Alzheimer’s cases each year globally, the need for better understanding and care is urgent.

AI-driven entrepreneurship offers a path to:

• Systematically study complex brain disorders
• Improve care delivery
• Reduce the societal burden of neurological diseases